GelStat Corp GSAC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.00 / $0.00
- Market Cap
- $209,997.42
- Volume/Avg
- 7.3 Mil / 3.3 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
GelStat Corp is a consumer healthcare company operating in the US. It is engaged in the development and marketing of over-the-counter (OTC) and other non-prescription consumer healthcare products. The company's lead product is Gelstat Migraine, which is a patented OTC homeopathic drug for use as a first-line, acute treatment for migraine and migraine-like headaches. The Gelstat Migraine is developed to provide acute relief from headache pain as well as other symptoms associated with a migraine. The other products of the company include CHEWS 2 LOSE, which is a diet aide in the form of an all-natural appetite suppressant gum; All Natural Speed which targets specific quick-fix energy user groups; and GelStat Sleep, which provides relief from sleep disorders and their associated symptoms.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- —
- Website
- https://www.gelstat.com
Valuation
|
Metric
|
GSAC
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
GSAC
|
|---|---|
Quick Ratio | 0.00 |
Current Ratio | 0.01 |
Interest Coverage | −9.23 |
Quick Ratio
No chart available
Profitability
|
Metric
|
GSAC
|
|---|---|
Return on Assets (Normalized) | −479.03% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
No chart available
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Cmsyvtflpb | Bvjkqs | $69.8 Bil | |
ZTS
| Zoetis Inc Class A | Ptbtrrdrm | Mdry | $68.9 Bil | |
HLN
| Haleon PLC ADR | Brwgstzby | Vkv | $37.7 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Wvlykkx | Vctm | $14.8 Bil | |
VTRS
| Viatris Inc | Lbsdvkvhv | Smnq | $13.6 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Pbxwcmvy | Wlfwq | $11.9 Bil | |
CTLT
| Catalent Inc | Hvsnkbvc | Cnvvjh | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Ljdzzzl | Mchln | $4.2 Bil | |
CURLF
| Curaleaf Holdings Inc | Hlwrjpm | Pbrd | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Vnbhbvgty | Zxhbrsz | $3.5 Bil |